Protective effects of miR-24-2-5p in early stages of breast cancer bone metastasis.
Saved in:
| Title: | Protective effects of miR-24-2-5p in early stages of breast cancer bone metastasis. |
|---|---|
| Authors: | Puppo M; Research Unit UMR_S1033, LyOS, Faculty of Medicine Lyon-Est, INSERM, 7 Rue Guillaume Paradin, Lyon, 69372, France. margherita.puppo@gmail.com.; Université Claude Bernard Lyon 1, Villeurbanne, France. margherita.puppo@gmail.com.; Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, UK. margherita.puppo@gmail.com., Croset M; Research Unit UMR_S1033, LyOS, Faculty of Medicine Lyon-Est, INSERM, 7 Rue Guillaume Paradin, Lyon, 69372, France.; Université Claude Bernard Lyon 1, Villeurbanne, France., Ceresa D; IRCCS Ospedale Policlinico San Martino, Genova, Italy., Valluru MK; Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, UK., Canuas Landero VG; Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, UK., Hernandez Guadarrama M; Research Unit UMR_S1033, LyOS, Faculty of Medicine Lyon-Est, INSERM, 7 Rue Guillaume Paradin, Lyon, 69372, France.; Université Claude Bernard Lyon 1, Villeurbanne, France., Iuliani M; Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, Roma, 200 - 00128, Italy.; Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Via Alvaro del Portillo, Roma, 21 - 00128, Italy., Pantano F; Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, Roma, 200 - 00128, Italy.; Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Via Alvaro del Portillo, Roma, 21 - 00128, Italy., Dawn Ottewell P; Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, UK., Clézardin P; Research Unit UMR_S1033, LyOS, Faculty of Medicine Lyon-Est, INSERM, 7 Rue Guillaume Paradin, Lyon, 69372, France. philippe.clezardin@inserm.fr.; Université Claude Bernard Lyon 1, Villeurbanne, France. philippe.clezardin@inserm.fr.; Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, UK. philippe.clezardin@inserm.fr. |
| Source: | Breast cancer research : BCR [Breast Cancer Res] 2024 Dec 18; Vol. 26 (1), pp. 186. Date of Electronic Publication: 2024 Dec 18. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 100927353 Publication Model: Electronic Cited Medium: Internet ISSN: 1465-542X (Electronic) Linking ISSN: 14655411 NLM ISO Abbreviation: Breast Cancer Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39696397 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Protective effects of miR-24-2-5p in early stages of breast cancer bone metastasis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Puppo+M%22">Puppo M</searchLink>; Research Unit UMR&#95;S1033, LyOS, Faculty of Medicine Lyon-Est, INSERM, 7 Rue Guillaume Paradin, Lyon, 69372, France. margherita.puppo@gmail.com.; Université Claude Bernard Lyon 1, Villeurbanne, France. margherita.puppo@gmail.com.; Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, UK. margherita.puppo@gmail.com.<br /><searchLink fieldCode="AU" term="%22Croset+M%22">Croset M</searchLink>; Research Unit UMR&#95;S1033, LyOS, Faculty of Medicine Lyon-Est, INSERM, 7 Rue Guillaume Paradin, Lyon, 69372, France.; Université Claude Bernard Lyon 1, Villeurbanne, France.<br /><searchLink fieldCode="AU" term="%22Ceresa+D%22">Ceresa D</searchLink>; IRCCS Ospedale Policlinico San Martino, Genova, Italy.<br /><searchLink fieldCode="AU" term="%22Valluru+MK%22">Valluru MK</searchLink>; Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, UK.<br /><searchLink fieldCode="AU" term="%22Canuas+Landero+VG%22">Canuas Landero VG</searchLink>; Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, UK.<br /><searchLink fieldCode="AU" term="%22Hernandez+Guadarrama+M%22">Hernandez Guadarrama M</searchLink>; Research Unit UMR&#95;S1033, LyOS, Faculty of Medicine Lyon-Est, INSERM, 7 Rue Guillaume Paradin, Lyon, 69372, France.; Université Claude Bernard Lyon 1, Villeurbanne, France.<br /><searchLink fieldCode="AU" term="%22Iuliani+M%22">Iuliani M</searchLink>; Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, Roma, 200 - 00128, Italy.; Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Via Alvaro del Portillo, Roma, 21 - 00128, Italy.<br /><searchLink fieldCode="AU" term="%22Pantano+F%22">Pantano F</searchLink>; Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, Roma, 200 - 00128, Italy.; Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Via Alvaro del Portillo, Roma, 21 - 00128, Italy.<br /><searchLink fieldCode="AU" term="%22Dawn+Ottewell+P%22">Dawn Ottewell P</searchLink>; Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, UK.<br /><searchLink fieldCode="AU" term="%22Clézardin+P%22">Clézardin P</searchLink>; Research Unit UMR&#95;S1033, LyOS, Faculty of Medicine Lyon-Est, INSERM, 7 Rue Guillaume Paradin, Lyon, 69372, France. philippe.clezardin@inserm.fr.; Université Claude Bernard Lyon 1, Villeurbanne, France. philippe.clezardin@inserm.fr.; Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, UK. philippe.clezardin@inserm.fr. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22100927353%22">Breast cancer research : BCR</searchLink> [Breast Cancer Res] 2024 Dec 18; Vol. 26 (1), pp. 186. <i>Date of Electronic Publication: </i>2024 Dec 18. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central+Ltd%22">BioMed Central Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100927353 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1465-542X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214655411%22">14655411 </searchLink><i>NLM ISO Abbreviation: </i>Breast Cancer Res <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39696397 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s13058-024-01934-2 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 186 Titles: – TitleFull: Protective effects of miR-24-2-5p in early stages of breast cancer bone metastasis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Puppo M – PersonEntity: Name: NameFull: Croset M – PersonEntity: Name: NameFull: Ceresa D – PersonEntity: Name: NameFull: Valluru MK – PersonEntity: Name: NameFull: Canuas Landero VG – PersonEntity: Name: NameFull: Hernandez Guadarrama M – PersonEntity: Name: NameFull: Iuliani M – PersonEntity: Name: NameFull: Pantano F – PersonEntity: Name: NameFull: Dawn Ottewell P – PersonEntity: Name: NameFull: Clézardin P IsPartOfRelationships: – BibEntity: Dates: – D: 18 M: 12 Text: 2024 Dec 18 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1465-542X Numbering: – Type: volume Value: 26 – Type: issue Value: 1 Titles: – TitleFull: Breast cancer research : BCR Type: main |
| ResultId | 1 |